Aster DM Healthcare Ltd Profit & Loss - Annual Report
Last Updated: July 2, 2024, 11:00 am
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
TTM
Sales
1,922
2,871
3,876
5,250
5,931
6,721
7,963
8,652
8,608
10,253
11,933
13,505
Expenses
1,660
2,421
3,370
4,805
5,582
6,089
6,886
7,187
7,506
8,720
10,307
11,693
Operating Profit
261
451
506
445
349
632
1,077
1,465
1,103
1,533
1,626
1,812
OPM %
14%
16%
13%
8%
6%
9%
14%
17%
13%
15%
14%
13%
Other Income
11
19
23
25
453
177
-155
-158
53
51
79
-14
Interest
45
48
79
189
371
204
205
391
334
307
390
395
Depreciation
76
111
144
243
322
298
306
586
618
641
780
895
Profit before tax
151
310
306
38
108
308
410
330
205
637
535
507
Tax %
4%
9%
11%
78%
10%
8%
10%
5%
13%
6%
11%
Net Profit
149
284
272
8
98
282
367
315
178
601
475
396
EPS in Rs
7.26
4.69
7.00
0.20
2.52
5.32
6.59
5.54
2.96
10.53
8.51
6.49
Dividend Payout %
0%
35%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Aster DM Healthcare Ltd Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2013-2014
2014-2015
2015-2016
2016-2017
2017-2018
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
YoY Net Profit Growth (%)
90.60%
-4.23%
-97.06%
1125.00%
187.76%
30.14%
-14.17%
-43.49%
237.64%
-20.97%
Change in YoY Net Profit Growth (%)
0.00%
-94.83%
-92.83%
1222.06%
-937.24%
-157.61%
-44.31%
-29.32%
281.13%
-258.61%
Aster DM Healthcare Ltd Growth
Compounded Sales Growth
10 Years:
3%
5 Years:
-14%
3 Years:
-25%
TTM:
-69%
Compounded Profit Growth
10 Years:
-3%
5 Years:
-24%
3 Years:
-5%
TTM:
-70%
Stock Price CAGR
10 Years:
%
5 Years:
21%
3 Years:
31%
1 Year:
25%
Return on Equity
10 Years:
8%
5 Years:
9%
3 Years:
9%
Last Year:
3%
Last Updated: June 18, 2024, 6:18 am
Aster DM Healthcare Ltd Balance Sheet
Last Updated: July 2, 2024, 11:00 am
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Sep 2023
Equity Capital
125
375
389
403
403
505
505
497
497
500
500
500
Reserves
654
536
1,096
17
1,472
2,327
2,709
2,775
2,875
3,080
3,574
3,874
Preference Capital
0
0
0
0
0
0
0
0
0
374
374
Borrowings
505
886
1,091
3,321
2,758
2,352
2,788
5,605
4,804
4,907
5,700
5,995
Other Liabilities
856
1,097
1,834
2,003
2,171
2,296
2,926
3,528
3,444
4,035
5,062
5,340
Total Liabilities
2,140
2,894
4,409
5,743
6,804
7,479
8,928
12,405
11,620
12,521
14,836
15,708
Fixed Assets
872
1,087
2,237
2,507
3,520
3,738
4,289
7,124
6,749
7,009
9,052
9,441
CWIP
185
357
197
358
290
402
550
736
934
998
279
395
Investments
6
7
3
39
32
38
22
34
63
45
80
36
Other Assets
1,077
1,442
1,972
2,839
2,962
3,302
4,067
4,511
3,874
4,470
5,425
5,835
Total Assets
2,140
2,894
4,409
5,743
6,804
7,479
8,928
12,405
11,620
12,521
14,836
15,708
Aster DM Healthcare Ltd Reserves and Borrowings Chart
Aster DM Healthcare Ltd Cash Flow
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Cash from Operating Activity
236
203
361
537
601
1,223
1,569
1,314
1,834
Cash from Investing Activity
-439
-775
-1,136
-522
-702
-658
-333
-563
-951
Cash from Financing Activity
203
578
654
46
134
-675
-1,116
-686
-817
Net Cash Flow
-1
5
-122
61
33
-110
120
65
66
Aster DM Healthcare Ltd Free Cash Flow
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Free Cash Flow
261.00
451.00
506.00
445.00
349.00
632.00
1.00
1.00
1.00
-373.00
-373.00
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
Undervalued: 6.53% compared to the current price 340
Intrinsic Value: 373.86
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.
Undervalued: 9.96% compared to the current price ₹340
Last 5 Year EPS CAGR: 3.22%
*Investments are subject to market risks
Strength and Weakness of Aster DM Healthcare Ltd Stock
Strength
Weakness
The stock has a low average Cash Conversion Cycle of -22.36, which is a positive sign.
The company has higher reserves (2,082.42 cr) compared to borrowings (62.33 cr), indicating strong financial stability.
The company has shown consistent growth in sales (6.58 cr) and profit (320.42 cr) over the years.
The stock has a low average ROCE of 8.73%, which may not be favorable.
The stock has a high average Working Capital Days of 54.82, which may not be favorable.
Should I Buy Aster DM Healthcare Ltd Share Now?
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aster DM Healthcare Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 2.83% (Industry Average ROE: %)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
✗ Stock P/E: 136 (Industry average Stock P/E: )
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.14
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:★★★★☆
About the Company - Aster DM Healthcare Ltd
Aster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company’s Corporate Identification Number(CIN) is L85110KA2008PLC147259 and registration number is 021703. Currently Company is involved in the business activities of Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores. Company’s Total Operating Revenue is Rs. 1116.47 Cr. and Equity Capital is Rs. 497.22 Cr. for the Year ended 31/03/2022.
INDUSTRY
ADDRESS
CONTACT
Hospitals & Medical Services
No.1785, Sarjapur Road, Sector -1, Bengaluru Kerala 560102
Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Aster DM Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
